• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

东南亚患者肾移植后第一年的骨丢失发生率和模式。

Prevalence and patterns of bone loss in the first year after renal transplant in South East Asian patients.

机构信息

Department of Endocrinology, Singapore General Hospital, Outram Road, Singapore.

出版信息

Transplantation. 2011 Sep 15;92(5):557-63. doi: 10.1097/TP.0b013e3182279152.

DOI:10.1097/TP.0b013e3182279152
PMID:21832963
Abstract

BACKGROUND

Limited data are available regarding patterns of bone loss in South East Asian renal transplant patients. We aimed to determine the prevalence of low bone density and factors contributing to bone loss in Singaporean patients in the first year after renal transplant.

METHODS

Seventy-nine consecutive patients who underwent renal transplant were evaluated. Bone mineral density (BMD) was evaluated at 0 (baseline), and at 6 and 12 months after transplant. Baseline parathyroid hormone and vitamin D levels were also assessed. Multivariate regression models were used to investigate the relationship between the different variables and BMD.

RESULTS

Thirty-six patients (45.6%) had low BMD at baseline. Factors correlating with the low BMD were older age, postmenopausal status, and tertiary hyperparathyroidism (P<0.0005, 0.009, and 0.027, respectively). There was a linear decrease in total hip and lumbar spine BMD from baseline to 12 months, the decrease from baseline to 6 months being significant (P=0.019 for total hip and P<0.0005 for lumbar spine). Patients with tertiary hyperparathyroidism had a greater risk of decrease in BMD at 6 months compared with patients with secondary hyperparathyroidism (odds ratio=13.5, confidence interval: 1.3, 144.4) and with those who had parathyroidectomy (odds ratio=34.9; confidence interval: 2.0, 598.8).

CONCLUSIONS

The prevalence of low BMD in this population of renal transplant recipients was high. Parathyroid status was the only independent factor that correlated with low BMD at baseline and subsequent bone loss highlighting the critical role of this hormone in bone metabolism after renal transplant.

摘要

背景

关于东南亚肾移植患者骨丢失模式的数据有限。我们旨在确定新加坡患者在肾移植后第一年低骨密度的患病率以及导致骨丢失的因素。

方法

评估了 79 例连续接受肾移植的患者。在移植后 0(基线)、6 和 12 个月评估骨矿物质密度(BMD)。还评估了基线甲状旁腺激素和维生素 D 水平。使用多元回归模型来研究不同变量与 BMD 之间的关系。

结果

36 例患者(45.6%)基线时存在低 BMD。与低 BMD 相关的因素是年龄较大、绝经后状态和三级甲状旁腺功能亢进(P<0.0005、0.009 和 0.027,分别)。从基线到 12 个月,总髋部和腰椎 BMD 呈线性下降,从基线到 6 个月的下降具有统计学意义(总髋部 P=0.019,腰椎 P<0.0005)。与二级甲状旁腺功能亢进患者和甲状旁腺切除术患者相比,三级甲状旁腺功能亢进患者 6 个月时 BMD 下降的风险更高(比值比=13.5,置信区间:1.3,144.4)和(比值比=34.9;置信区间:2.0,598.8)。

结论

该人群肾移植受者低骨密度的患病率较高。甲状旁腺状态是与基线时低 BMD 以及随后的骨丢失相关的唯一独立因素,这突出了该激素在肾移植后骨代谢中的关键作用。

相似文献

1
Prevalence and patterns of bone loss in the first year after renal transplant in South East Asian patients.东南亚患者肾移植后第一年的骨丢失发生率和模式。
Transplantation. 2011 Sep 15;92(5):557-63. doi: 10.1097/TP.0b013e3182279152.
2
Early bone mineral density loss after renal transplantation and pre-transplant PTH: a prospective study.肾移植后早期骨矿物质密度丧失与移植前甲状旁腺激素:一项前瞻性研究。
Kidney Blood Press Res. 2008;31(3):196-202. doi: 10.1159/000137287. Epub 2008 Jun 6.
3
Prevalence of osteoporosis, osteopenia, and vertebral fractures in long-term renal transplant recipients.长期肾移植受者骨质疏松症、骨质减少症和椎体骨折的患病率。
Transplant Proc. 2007 Sep;39(7):2256-8. doi: 10.1016/j.transproceed.2007.07.073.
4
Bone mineral density changes within 11 months of renal transplantation in Iranian patients.伊朗患者肾移植后11个月内的骨矿物质密度变化
Transplant Proc. 2007 May;39(4):1039-43. doi: 10.1016/j.transproceed.2007.03.083.
5
Bone mineral disorders in pediatric and adolescent renal transplant recipients.儿科和青少年肾移植受者的骨矿物质紊乱
Pediatr Transplant. 2011 Jun;15(4):367-75. doi: 10.1111/j.1399-3046.2011.01492.x. Epub 2011 Mar 23.
6
Osteoporosis in lung transplantation candidates with end-stage pulmonary disease.终末期肺病肺移植候选者中的骨质疏松症
Am J Med. 1996 Sep;101(3):262-9. doi: 10.1016/S0002-9343(96)00155-6.
7
The effect of low-dose cholecalciferol and calcium treatment on posttransplant bone loss in renal transplant patients: a prospective study.低剂量胆钙化醇和钙治疗对肾移植患者移植后骨质流失的影响:一项前瞻性研究。
Ren Fail. 2008;30(10):992-9. doi: 10.1080/08860220802406369.
8
Age, body mass index, and serum prostate-specific antigen correlate with bone loss in men with prostate cancer not receiving androgen deprivation therapy.年龄、体重指数和血清前列腺特异性抗原与未接受雄激素剥夺治疗的前列腺癌男性的骨质流失相关。
Urology. 2004 Aug;64(2):335-40. doi: 10.1016/j.urology.2004.03.036.
9
Bone loss after kidney transplantation: a longitudinal study in 115 graft recipients.肾移植后骨质流失:115例移植受者的纵向研究
Nephrol Dial Transplant. 1995 Nov;10(11):2096-100.
10
Inverse association of serum long-acting natriuretic peptide and bone mineral density in renal transplant recipients.肾移植受者血清长效利钠肽与骨密度呈负相关。
Clin Transplant. 2012 Mar-Apr;26(2):E105-10. doi: 10.1111/j.1399-0012.2011.01575.x. Epub 2011 Dec 29.

引用本文的文献

1
Bone Density Reduction and Its Associated Factors in Kidney Transplant Recipients: A Cross-Sectional Study.肾移植受者的骨密度降低及其相关因素:一项横断面研究。
Int J Organ Transplant Med. 2022;13(1):5-11.
2
Factors Related to Bone Metabolism in Kidney Transplant Recipients.肾移植受者骨代谢相关因素。
Mediators Inflamm. 2021 Jan 13;2021:6679095. doi: 10.1155/2021/6679095. eCollection 2021.
3
Efficacy and Safety of Bisphosphonates for Low Bone Mineral Density After Kidney Transplantation: A Meta-Analysis.双膦酸盐对肾移植后低骨密度的疗效及安全性:一项荟萃分析
Medicine (Baltimore). 2016 Feb;95(5):e2679. doi: 10.1097/MD.0000000000002679.
4
Mineral and bone disorder after kidney transplantation.肾移植后的矿物质与骨代谢紊乱
World J Transplant. 2015 Dec 24;5(4):231-42. doi: 10.5500/wjt.v5.i4.231.